Page 31 - Nomenclature of Inorganic Chemistry (IUPAC Recommendations 2005)
P. 31

G R A M  M  A R                                                     I  R-2.2





                       (g) In the Kro ¨ger–Vink notation (see Section IR-11.4), to indicate a  c omplex  d efect.

                       Example:
                          13. (Cr Mg V Mg Cr Mg ) x


                       (h) For crystalline substances, to indicate the type of crystal formed (see Chapter I R-11).

                       Examples:
                          14. ZnS(c)

                          15. AuCd (CsCl type)

                       (i) To enclose a  s ymbol representing the state of aggregation of a  c hemical species.

                       Example:
                          16. HCl(g)        hydrogen chloride in the gaseous state


                       (j) In optically  a ctive compounds, to enclose the signs  o f  r otation.

                       Example:

                          17. (þ) 589 -[Co(en) 3 ]Cl 3

                       (k) To enclose stereodescriptors, such as chirality descriptors and configuration indexes
                       (see Section IR-9.3.3.2).

                       Examples:

                          18. (2R,3S)-SiH 2 ClSiHClSiHClSiH 2 SiH 3
                          19. (OC-6-22)-[Co(NH 3 ) 3 (NO 2 ) 3 ]


                       (l) In polymers, the repeating unit is enclosed in strike-through parentheses, with the dash
                       superimposed on the parentheses representing the bond. 3

                       Example:

                          20.  ðS Þ n

           IR-2.2.3.2  Use in names

                       Parentheses are used in names in the following ways.
                       (a) To enclose substituent g roup or ligand names in order to avoid ambiguity, for example if
                       the substituent g roup or ligand names contain multiplicative prefixes, such as (dioxido) or
                       (triphosphato), o r  i f s ubstitution patterns would otherwise  n ot be unambiguously specified,
                       or if the substituent g roup or ligand name c ontains n umerical or letter descriptors. It may be
                       necessary  t o  u  se different enclosing marks  i f  t he ligand names or substituent groups
                       themselves include parentheses, cf. t he nesting rule  o f S ection IR-2.2.1.


                       22
   26   27   28   29   30   31   32   33   34   35   36